JAMA Oncology Author Interviews

Interview with Jeanne Tie, author of Prognostic Potential of Circulating Tumor DNA Measurement in Postoperative Surveillance of Nonmetastatic Colorectal Cancer

Interview with Quynh-Nhu Nguyen, M.D., author of Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial

Interview with David Urbach, author of The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms

Interview with David A. Palma, MD, PhD, author of Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer: A Phase 2 Clinical Trial

Interview with Joseph M. Unger, PhD, author of Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation

Interview with Andrew J. Dannenberg, MD, author of Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study

Interview with Anthony D'Amico, MD, PhD, author of Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

Interview with Mollie E. Barnard, ScD, and Shelley Tworoger, PhD, authors of Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies , and Andrew T. Chan, MD, MPH, author of Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

Interview with Benjamin Besse, MD, author of Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Interview with Francesca Gay, author of Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

Interview with Nora Pashayan, BSc MSc MSt MD PhD FFPH, author of Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model

Interview with Aaron Goodman, MD, author of Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors

Interview with Allison W. Kurian, M.D., M.Sc., author of Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer

Interview with Erin L. Van Blarigan, ScD, and Jeffrey A Meyerhardt, MD, MPH, authors of Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial

Interview with Jeff Michalski, MD, author of Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial

Interview with Daniel P. Petrylak, MD, PhD, author of Atezolizumab (MPDL3280A) Monotherapy for Patients With Metastatic Urothelial Cancer: Long-term Outcomes From a Phase 1 Study

Interview with Fred K. Tabung, and Charles S. Fuchs, MD, MPH, authors of Association of Dietary Inflammatory Potential With Colorectal Cancer Risk in Men and Women

Interview with Martin R. Weiser, MD, author of Association of Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome

Interview with Douglas W. Blayney, MD, author of Critical Lessons From High-Value Oncology Practices

Interview with Kosmas Daskalakis, MD, author of Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival

Interview with Nonniekaye Shelburne, BSN, MS, and Demetrios Kyriacou, authors of Trends in Adult Cancer–Related Emergency Department Utilization: An Analysis of Data From the Nationwide Emergency Department Sample

Interview with Sharon A. Savage, MD, author of Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort

Interview with Mary-Claire King, author of Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women

Interview with Monica Morrow, MD, author of Trends in Reoperation After Initial Lumpectomy for Breast Cancer: Addressing Overtreatment in Surgical Management

Interview with Martin G. Sanda, MD, author of Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate Cancer